| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443915 | European Journal of Cancer | 2013 | 13 Pages |
Abstract
The application of metabolomics for biomarker detection in OG cancer presents new opportunities for the purposes of screening and therapeutic monitoring. Future studies should provide clear details of patient selection and develop metabolite assays suitable for progress beyond phase 1 pre-clinical exploratory studies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
N. Abbassi-Ghadi, S. Kumar, J. Huang, R. Goldin, Z. Takats, G.B. Hanna,